Clinical and radiologic rebound after discontinuation of natalizumab therapy in a highly active multiple sclerosis patient was not halted by dimethyl-fumarate: a case report

Multiple Sclerosis

Serum sickness (Like Reaction) in a patient treated with alemtuzumab for multiple sclerosis: A case report

Mult Scler Relat Disord.

Lapucci C, Gualandi F, Mikulska M, Palmeri S, Mancardi G, Uccelli A, Laroni A

doi: 10.1016/j.msard.2018.09.006.

Multiple Sclerosis

Efficacy of Natalizumab in Intermediate Uveitis Related to Multiple Sclerosis: A Case Report

doi: 10.1055/s-0043-124756.

Multiple Sclerosis

Cryptococcal meningoencephalitis in an IgG₂-deficient patient with multiple sclerosis on fingolimod therapy for more than five years - case report

BMC Neurol.

Wienemann T, Müller AK, MacKenzie C, Bielor C, Weyers V, Aktas O, Hartung HP, Kremer D

doi: 10.1186/s12883-020-01741-0.

Further Publications NeurologyFurther Publications Psychiatry

Severe disease activity in a patient with multiple sclerosis after daclizumab discontinuation

Mult Scler Relat Disord.

Martinelli V, Dalla Costa G, Sangalli F, Colombo B, Robotti M, Moiola L, Comi G

doi: 10.1016/j.msard.2018.11.034.

Multiple Sclerosis

Secukinumab for patients with plaque psoriasis affected by multiple sclerosis. A mini-review with a representative case report

J Eur Acad Dermatol Venereol.

Venturini M, Zanca A, Venturuzzo A, Filippini M, Frassi M, Tincani A, Calzavara-Pinton PG

doi: 10.1111/jdv.16035.

Multiple Sclerosis

Early predictors of rapidly evolving multiple sclerosis: A case report

J Neuroimmunol.

Fernando KTM, James M

doi: 10.1016/

Multiple Sclerosis

Clinical experience with repository corticotropin injection in patients with multiple sclerosis experiencing mood changes with intravenous methylprednisolone: a case series

Ther Adv Neurol Disord.

Murray S, Woo A

doi: 10.1177/1756285615618642.

Multiple Sclerosis

The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis

PLoS One.

Tsivgoulis G, Katsanos AH, Grigoriadis N, Hadjigeorgiou GM, Heliopoulos I, Papathanasopoulos P, Kilidireas C, Voumvourakis K, Dardiotis E; HELANI (Hellenic Academy of Neuroimmunology)

doi: 10.1371/

Multiple Sclerosis

Autologous hematopoietic stem cell transplantation following alemtuzumab therapy in aggressive multiple sclerosis: A report of three cases

Mult Scler.

Boffa G, Sbragia E, Raiola AM, Varaldo R, Capello E, Gallo P, Granella F, Mancardi G, Inglese M

doi: 10.1177/1352458520914818.

Related content

Serum sickness (Like Reaction) in a patient treated with alemtuzumab for multiple sclerosis: A case report

Efficacy of Natalizumab in Intermediate Uveitis Related to Multiple Sclerosis: A Case Report

Cryptococcal meningoencephalitis in an IgG2-deficient patient with multiple sclerosis on fingolimod therapy for more than five years - case report

Severe disease activity in a patient with multiple sclerosis after daclizumab discontinuation

Secukinumab for patients with plaque psoriasis affected by multiple sclerosis. A mini-review with a representative case report

Early predictors of rapidly evolving multiple sclerosis: A case report

Clinical experience with repository corticotropin injection in patients with multiple sclerosis experiencing mood changes with intravenous methylprednisolone: a case series

The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis

Autologous hematopoietic stem cell transplantation following alemtuzumab therapy in aggressive multiple sclerosis: A report of three cases

Cryptococcal meningoencephalitis in an IgG₂-deficient patient with multiple sclerosis on fingolimod therapy for more than five years - case report